These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 11234403

  • 1. [Endonuclease from Proteus mirabilis].
    Salikhova ZZ, Sokolova RB, Ponomareva AZ, Iusupova DV.
    Prikl Biokhim Mikrobiol; 2001; 37(1):43-7. PubMed ID: 11234403
    [Abstract] [Full Text] [Related]

  • 2. [Biosynthesis of Proteus mirabilis nuclease].
    Salikhova ZZ, Sokolova RB, Iusupova DV.
    Mikrobiologiia; 2000; 69(6):778-82. PubMed ID: 11195576
    [Abstract] [Full Text] [Related]

  • 3. [Deoxyribonuclease of Proteus mirabilis].
    Iusupova DV, Sokolova RB, Gedze GI.
    Vopr Med Khim; 1983; 29(2):29-35. PubMed ID: 6344422
    [Abstract] [Full Text] [Related]

  • 4. [Phosphatase from Proteus mirabilis].
    Salikhova ZZ, Sokolova RB, Iusupova DV.
    Prikl Biokhim Mikrobiol; 2001; 37(2):170-4. PubMed ID: 11357420
    [Abstract] [Full Text] [Related]

  • 5. First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis.
    Bidet P, Verdet C, Gautier V, Bingen E, Arlet G.
    Clin Microbiol Infect; 2005 Jul; 11(7):591-2. PubMed ID: 15966982
    [Abstract] [Full Text] [Related]

  • 6. [Isolation and characterization of Proteus mirabilis mutants deficient in DNA degradation: function of endonuclease I in postmortem DNA degradation].
    Steinborn G, Hofemeister J, Böhme H.
    Z Allg Mikrobiol; 1977 Jul; 17(6):451-8. PubMed ID: 337689
    [Abstract] [Full Text] [Related]

  • 7. [Induction of synthesis of extracellular DNAase from Proteus mirabilis under the effect of compounds, blocking DNA replication].
    Iusupova DV, Sanzhmiatavyn E, Sokolova RB, Petukhova EV.
    Mol Gen Mikrobiol Virusol; 1993 Jul; (3):36-9. PubMed ID: 8350881
    [Abstract] [Full Text] [Related]

  • 8. [Isolation and purification of restriction endonuclease PmiI from Proteus mirabilis 1667].
    Bakh NL, Tsvetkova NV, Semina IE, Tarasov AP, Mileĭkovskaia MM.
    Antibiot Med Biotekhnol; 1985 May; 30(5):342-4. PubMed ID: 2992364
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin).
    Carson L, Cathcart GR, Scott CJ, Hollenberg MD, Walker B, Ceri H, Gilmore BF.
    Biochimie; 2011 Oct; 93(10):1824-7. PubMed ID: 21762758
    [Abstract] [Full Text] [Related]

  • 10. Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 beta-lactamases at 2 hospitals in Taiwan.
    Wu LT, Wu HJ, Chung JG, Chuang YC, Cheng KC, Yu WL.
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):89-94. PubMed ID: 16406185
    [Abstract] [Full Text] [Related]

  • 11. Characterisation of a thiamine diphosphate-dependent alpha-keto acid decarboxylase from Proteus mirabilis JN458.
    Wang B, Bai Y, Fan T, Zheng X, Cai Y.
    Food Chem; 2017 Oct 01; 232():19-24. PubMed ID: 28490063
    [Abstract] [Full Text] [Related]

  • 12. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.
    Coudron PE.
    J Clin Microbiol; 2005 Aug 01; 43(8):4163-7. PubMed ID: 16081966
    [Abstract] [Full Text] [Related]

  • 13. ZapA, a possible virulence factor from Proteus mirabilis exhibits broad protease substrate specificity.
    Anéas MA, Portaro FC, Lebrun I, Juliano L, Palma MS, Fernandes BL.
    Braz J Med Biol Res; 2001 Nov 01; 34(11):1397-403. PubMed ID: 11668347
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a periplasmic S1-like nuclease coded by the Mesorhizobium loti symbiosis island.
    Pimkin M, Miller CG, Blakesley L, Oleykowski CA, Kodali NS, Yeung AT.
    Biochem Biophys Res Commun; 2006 Apr 28; 343(1):77-84. PubMed ID: 16529713
    [Abstract] [Full Text] [Related]

  • 15. Purification and properties of glucosaminephosphate isomerase of Proteus mirabilis.
    Cifuentes B, Vicente C.
    Z Naturforsch C Biosci; 1982 Apr 28; 37(5-6):381-4. PubMed ID: 7051594
    [Abstract] [Full Text] [Related]

  • 16. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides.
    McCoy AJ, Liu H, Falla TJ, Gunn JS.
    Antimicrob Agents Chemother; 2001 Jul 28; 45(7):2030-7. PubMed ID: 11408219
    [Abstract] [Full Text] [Related]

  • 17. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis.
    Park YJ, Lee S, Kim YR, Oh EJ, Woo GJ, Lee K.
    J Antimicrob Chemother; 2006 Jan 28; 57(1):156-8. PubMed ID: 16284101
    [No Abstract] [Full Text] [Related]

  • 18. gamma-Glutamyltranspeptidase from Proteus mirabilis: localization and activation by phospholipids.
    Nakayama R, Kumagai H, Tochikura T.
    J Bacteriol; 1984 Dec 28; 160(3):1031-6. PubMed ID: 6150026
    [Abstract] [Full Text] [Related]

  • 19. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.
    D'Andrea MM, Nucleo E, Luzzaro F, Giani T, Migliavacca R, Vailati F, Kroumova V, Pagani L, Rossolini GM.
    Antimicrob Agents Chemother; 2006 Feb 28; 50(2):618-24. PubMed ID: 16436718
    [Abstract] [Full Text] [Related]

  • 20. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis.
    Mahrouki S, Ben-Achour N, Chouchani C, Ben-Moussa M, Belhadj O.
    Pathol Biol (Paris); 2009 May 28; 57(3):e55-9. PubMed ID: 18456422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.